In an era when congenital syphilis is resurging across Europe, Denmark has demonstrated that a preventable disease can be stopped at the threshold of birth itself. Since 2010, the country has offered universal, free first-trimester syphilis screening to every pregnant woman, achieving a decade without a single case of mother-to-child transmission — even as infections rose in the broader population. The World Health Organization formally recognized this achievement in September 2026, not as a stroke of luck, but as the fruit of sustained, systemic commitment to reaching the vulnerable before ha
Denmark eliminates congenital syphilis through universal prenatal screening
Congenital syphilis can cause stillbirth, preterm birth, neonatal death, and serious long-term complications; Denmark's program prevented these outcomes in vulnerable populations.
Elimination is possible, but only if the commitment is sustained.
Mark
So Denmark has zero cases of congenital syphilis for ten years, but syphilis is actually increasing in the general population. How does that work?
Mimi
The screening program catches infections in pregnant women before they can be passed to the baby. Nearly 100 percent of pregnant women are tested in the first trimester, and nearly 100 percent of those who test positive are treated with antibiotics. The disease doesn't reach the child.
Luke
But I want to be careful here. The data shows five cases between 2010 and 2024, not zero. Four happened because women arrived late in pregnancy or got infected late. One was a reporting delay. So the program isn't perfect—it's just very good at catching cases early.
Mimi
That's fair. And it's important because it shows the program works within the real world, where some women do arrive late and some infections do happen at the margins.
Mark
Why is congenital syphilis such a big deal if it can be treated?
Mimi
If it's not treated, it can cause stillbirth, premature birth, death of the newborn, or serious lifelong complications. Once the baby is born with it, the damage is done. Prevention is the only real solution.
Luke
And the numbers matter here. We're talking about nearly one million women tested over 15 years. That's the scale required to maintain this kind of elimination.
Mark
So what's the lesson for other European countries where cases are doubling?
Mimi
Denmark shows that even when syphilis is increasing in the general population, you can prevent it from reaching babies if you have universal screening, prompt treatment, and a functioning healthcare system to deliver both.
Luke
The question is whether other countries can sustain that level of coverage and follow-up. Denmark's doing it, but it requires consistent resources and infrastructure.
Der Puls
- Across 14 European countries, congenital syphilis cases nearly doubled in a single year — from 78 to 140 — while Denmark recorded zero for a full decade, exposing a stark and preventable divide.
- The disease carries devastating stakes: stillbirth, premature delivery, neonatal death, and lifelong complications hang in the balance when infections go undetected during pregnancy.
- Denmark's near-perfect 99% testing coverage across almost one million pregnant women proved that universal access, not selective screening, is the variable that closes the gap between risk and protection.
- Critically, only 10% of initial positive tests reflected active infection, meaning the system also protects against overtreatment — a precision that builds trust and sustains participation.
- The WHO's formal recognition of Denmark's elimination status in 2026 transforms a national success into an international blueprint, arriving precisely when neighboring countries need it most.
In an era when congenital syphilis is resurging across Europe, Denmark has demonstrated that a preventable disease can be stopped at the threshold of birth itself. Since 2010, the country has offered universal, free first-trimester syphilis screening to every pregnant woman, achieving a decade without a single case of mother-to-child transmission — even as infections rose in the broader population. The World Health Organization formally recognized this achievement in September 2026, not as a stroke of luck, but as the fruit of sustained, systemic commitment to reaching the vulnerable before harm can pass to the next generation.
Congenital syphilis — transmitted from mother to child during pregnancy and capable of causing stillbirth, premature birth, or severe lifelong harm — is rising sharply across Europe. In a single recent year, reported cases among 14 countries nearly doubled, from 78 to 140. Denmark, meanwhile, has not recorded a single case of vertical transmission since 2016.
The foundation of Denmark's achievement is straightforward: since 2010, every pregnant woman has been offered free syphilis screening during her first trimester, administered through general practitioners as part of routine prenatal care. Over 15 years, nearly one million women were tested — 963,424 in total — with a coverage rate of 99 percent. Among those who tested positive, treatment uptake reached close to 100 percent. Across almost 900,000 live births during this period, only five children were born with congenital syphilis, and each of those rare cases traced back to late presentation or a reporting delay rather than a failure of the program itself.
Dr. Ulrik Lausten-Thomsen and colleagues at Copenhagen University Hospital Rigshospitalet published the findings in Eurosurveillance, revealing a detail that sharpens the picture: of 1,720 pregnant women who initially screened positive, only 172 had confirmed active infections. The program's ability to distinguish active disease from past infection or false positives allowed clinicians to treat precisely those who needed it — no more, no less.
What makes the result especially striking is that syphilis notifications in Denmark's general population have been climbing at roughly 6 percent annually, including among women of childbearing age. The screening program has simply prevented that rising tide from reaching newborns. When infection is caught during pregnancy, prompt antibiotic treatment is highly effective — but only if the system reliably identifies, follows up, and treats every case.
Denmark has now met both of the WHO's elimination benchmarks ahead of schedule — fewer than 10 cases per 100,000 live births by 2025, and one or fewer by 2030 — and in September 2026, the WHO formally recognized the country's elimination status. As other European nations struggle with rising congenital syphilis despite existing screening programs, Denmark's experience offers a clear lesson: the difference is not having less disease in the population, but maintaining the universal infrastructure to stop it before it can pass to the next generation.
Across Europe, congenital syphilis is surging. In a single year, cases nearly doubled from 78 to 140 among the 14 countries that reported data to health authorities. The disease, transmitted from mother to child during pregnancy, can cause stillbirth, premature delivery, neonatal death, or severe lifelong complications if left untreated. Yet Denmark has not recorded a single case of vertical transmission in a decade.
The country's achievement rests on a deceptively simple foundation: since 2010, Denmark has offered free syphilis screening to every pregnant woman during her first trimester visit, delivered through general practitioners as part of routine prenatal care. Over 15 years, this universal approach tested nearly one million pregnant women—963,424 in total—with a testing rate of 99 percent. Among those who tested positive, treatment uptake reached nearly 100 percent. The results speak plainly: between 2010 and 2024, only five children were born with congenital syphilis across almost 900,000 live births in Denmark. Four of those five cases occurred because the mothers either arrived late in pregnancy or contracted the infection late in their pregnancy. The fifth resulted from a reporting delay that prevented timely follow-up.
Dr. Ulrik Lausten-Thomsen, a senior neonatologist at Copenhagen University Hospital Rigshospitalet, and his colleagues published their findings in the journal Eurosurveillance, examining screening coverage, infection rates, confirmed cases, and live births year by year. The data revealed a critical detail: of 1,720 pregnant women who initially tested positive for syphilis, only 172—roughly 10 percent—had confirmed active infection after additional testing. This distinction matters. It means the screening program catches not just active disease but also past infections and false positives, allowing clinicians to treat only those who need treatment and avoid unnecessary intervention.
What makes Denmark's result even more striking is the context in which it was achieved. The researchers found that syphilis notifications in the general Danish population have been rising, with an average annual increase of around 6 percent. Cases among women of childbearing age—15 to 49 years old—have also climbed. Yet this upward trend in the broader population has not translated into a single case of congenital syphilis since 2016. The screening program, in other words, is working precisely as intended: it catches infections before they can be transmitted to the next generation, regardless of how common the disease becomes in adults.
The mechanism is straightforward but requires discipline. When syphilis is detected during pregnancy, prompt antibiotic therapy is highly effective at preventing transmission. The challenge is ensuring that every pregnant woman is screened, that results are followed up, and that treatment is offered and completed. Denmark's healthcare system has maintained these standards consistently for 15 years, even as the disease has become more common.
Lausten-Thomsen and his colleagues note that the prevalence of confirmed active syphilis in pregnant women has remained stable over the study period, despite rising notifications elsewhere. This stability, combined with zero congenital cases for a decade, points to a healthcare system that is functioning well at the critical juncture: diagnosis and treatment before pregnancy can harm a child. The researchers emphasize that this outcome did not happen by accident. It required sustained attention to vulnerable populations and early engagement with pregnant women at their first antenatal visit.
Denmark has now met the World Health Organization's benchmarks for congenital syphilis elimination ahead of schedule. The WHO set a target of fewer than 10 cases per 100,000 live births by 2025 and 1 case or fewer by 2030. Denmark achieved both thresholds early, and in September 2026, the WHO officially recognized the country as having eliminated congenital syphilis. The data from Lausten-Thomsen's study contributed directly to that decision.
The contrast with the rest of Europe is instructive. While Denmark has held the line, other countries have seen cases nearly double in a single year. The difference is not that Denmark has less syphilis in its population—it has more. The difference is that Denmark screens universally, treats promptly, and maintains the infrastructure to do both consistently. As other European nations grapple with rising congenital syphilis, Denmark's experience offers both a roadmap and a reminder: elimination is possible, but only if the commitment to screening and treatment is sustained.
Bemerkenswerte Zitate
Results highlight the public health value of maintaining high screening coverage and robust surveillance, even in low-incidence countries.— Dr. Ulrik Lausten-Thomsen and colleagues, Eurosurveillance
Despite increasing syphilis notifications in the general population, including among women aged 15–49 years, we observed no temporal increase in congenital syphilis.— Dr. Ulrik Lausten-Thomsen and colleagues
Möchten Sie die ganze Geschichte?
Das Original lesen bei healthcare-in-europe.com ↗
General News